Aventis Menactra May Get CDC Endorsement For Teens And College Freshmen
Executive Summary
A working group of the Centers for Disease Control & Prevention's Advisory Committee on Immunization Practices favors a future recommendation of routine vaccination with meningococcal vaccine for adolescents and college freshmen in dorms
You may also be interested in...
Menactra Needs Long-Term Safety, Efficacy Studies Post-Approval – Cmte.
Sanofi-Aventis should commit to long-term efficacy and safety post-approval studies for its quadravalent meningococcal conjugate vaccine Menactra (MCV-4), an FDA advisory committee said
Menactra Needs Long-Term Safety, Efficacy Studies Post-Approval – Cmte.
Sanofi-Aventis should commit to long-term efficacy and safety post-approval studies for its quadravalent meningococcal conjugate vaccine Menactra (MCV-4), an FDA advisory committee said
PhRMA, BIO Support Vaccines For Children Program For Underinsured
The Pharmaceutical Research & Manufacturers of America and the Biotechnology Industry Organization support expanding the Vaccines for Children program to the underinsured